Literature DB >> 9818031

Induction of apoptosis in human pancreatic carcinoma cells by a synthetic bleomycin-like ligand.

R Suginaka1, R Izui, J Inoue, Y Muraoka, K Yamaguchi, M Otsuka, K Umezawa.   

Abstract

Histidine-pyridine-histidine-3 (HPH-3) is an oxygen-activating ligand based on the structure of bleomycin. HPH-3 induced the death of human pancreatic adenocarcinoma AsPC-1 cells in 24 h, causing apoptotic morphology and internucleosomal degradation of DNA. HPH-3-induced cell death was not inhibited by antioxidants such as reduced glutathione and N-acetylcysteine, whereas hydrogen peroxide-induced cell death was inhibited by them, indicating that hydrogen peroxide is not involved in the induction of apoptosis by HPH-3. Induction of apoptosis by HPH-3 was inhibited by zinc and copper ions, indicating that chelation with ferrous ion is responsible for induction of apoptosis, as is the case in chelation by bleomycin to cleave DNA. Bleomycin A2 and its fragment having no DNA-binding region, glycopeptide-3, did not induce apoptosis in AsPC-1 cells. Bleomycin A2 induced G2/M block in flow-cytometric analysis, but HPH-3 did not and instead induced an apoptotic pre-G1 peak. Thus, HPH-3 induced apoptosis in human pancreatic carcinoma cells, which is a unique characteristic among bleomycin-related compounds.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9818031      PMCID: PMC5921946          DOI: 10.1111/j.1349-7006.1998.tb00653.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  19 in total

1.  Bcl-2 functions in an antioxidant pathway to prevent apoptosis.

Authors:  D M Hockenbery; Z N Oltvai; X M Yin; C L Milliman; S J Korsmeyer
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

2.  Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor.

Authors:  N Meydan; T Grunberger; H Dadi; M Shahar; E Arpaia; Z Lapidot; J S Leeder; M Freedman; A Cohen; A Gazit; A Levitzki; C M Roifman
Journal:  Nature       Date:  1996-02-15       Impact factor: 49.962

3.  Involvement of hydrogen peroxide production in erbstatin-induced apoptosis in human small cell lung carcinoma cells.

Authors:  S Simizu; M Imoto; N Masuda; M Takada; K Umezawa
Journal:  Cancer Res       Date:  1996-11-01       Impact factor: 12.701

4.  A role for ferrous ion and oxygen in the degradation of DNA by bleomycin.

Authors:  E A Sausville; J Peisach; S B Horwitz
Journal:  Biochem Biophys Res Commun       Date:  1976-12-06       Impact factor: 3.575

Review 5.  The role of redox-active metals in the mechanism of action of bleomycin.

Authors:  D H Petering; R W Byrnes; W E Antholine
Journal:  Chem Biol Interact       Date:  1990       Impact factor: 5.192

6.  The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis.

Authors:  N Itoh; S Yonehara; A Ishii; M Yonehara; S Mizushima; M Sameshima; A Hase; Y Seto; S Nagata
Journal:  Cell       Date:  1991-07-26       Impact factor: 41.582

7.  Transforming growth factor beta 1-induced apoptosis in human ovarian carcinoma cells: protection by the antioxidant N-acetylcysteine and bcl-2.

Authors:  C Lafon; C Mathieu; M Guerrin; O Pierre; S Vidal; A Valette
Journal:  Cell Growth Differ       Date:  1996-08

8.  Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized.

Authors:  O Tounekti; G Pron; J Belehradek; L M Mir
Journal:  Cancer Res       Date:  1993-11-15       Impact factor: 12.701

9.  Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis.

Authors:  S M Laster; J G Wood; L R Gooding
Journal:  J Immunol       Date:  1988-10-15       Impact factor: 5.422

10.  Novel zinc chelators with dual activity in the inhibition of the kappa B site-binding proteins HIV-EP1 and NF-kappa B.

Authors:  M Otsuka; M Fujita; T Aoki; S Ishii; Y Sugiura; T Yamamoto; J Inoue
Journal:  J Med Chem       Date:  1995-08-18       Impact factor: 7.446

View more
  1 in total

1.  Radiotherapy and antiangiogenic TM in lung cancer.

Authors:  Mohamed K Khan; Meredith W Miller; Jeremy Taylor; Navkiranjit K Gill; Robert D Dick; Kenneth Van Golen; George J Brewer; Sofia D Merajver
Journal:  Neoplasia       Date:  2002 Mar-Apr       Impact factor: 5.715

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.